Skip to main content
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
FDA Oncology Update
FDA Oncology Update
A Dynamic FDA Has Led to More Rapid Cancer Drug Development
Wayne Kuznar
Read More
Leukemia
,
Drug Profiles/Updates
,
FDA Oncology Update
Quizartinib Significantly Improves Survival Over Chemotherapy in Patients with Relapsed/Refractory AML and FLT3-ITD Mutation
Read More
FDA Oncology Update
Actemra First FDA-Approved Treatment for CAR T-Cell–Induced Severe Cytokine Release Syndrome
Read More
FDA Oncology Update
Mylotarg Now Approved for the Treatment of Patients with CD33-Positive AML
Read More
FDA Oncology Update
Nivolumab Receives New Indication for dMMR and MSI-H Metastatic Colorectal Cancer
Read More
FDA Oncology Update
Besponsa a New Treatment Option for Patients with Relapsed/Refractory B-Cell ALL
Read More
FDA Oncology Update
Kymriah First Gene Therapy Approved by the FDA, Indicated for Young Patients with B-Cell ALL and CD19
Read More
FDA Oncology Update
FDA News - September 2017
Read More
FDA Oncology Update
FDA News - August 2017
Read More
FDA Oncology Update
FDA News - June 2017
Read More
5
6
7
8
9
10
11
Page 8 of 13
Results 71 - 80 of 121